SXSW 2027 Panel Voting Includes Cannabis and Psychedelics Proposals

August 20, 2026

Photo via Pexels.

If you've ever wanted a say in what gets discussed on stage at one of the biggest tech-culture-music mashups in the country, this is your week. SXSW's PanelPicker voting for the 2027 festival is open right now, and it closes this coming Sunday. Buried in the thousands of proposed sessions covering AI, film, and startup culture is a smaller but notable batch tied to cannabis and psychedelics -- seven proposals mentioning marijuana in their descriptions, and 20 touching on psychedelics. That's a steep drop from what the festival has fielded in recent years.

SXSW 2027 runs March 15-21 in Austin, Texas, and like every year, the final lineup isn't decided by public vote alone. Community voting is one ingredient in a mix that also includes SXSW staff picks and an advisory evaluator committee. Still, the public vote carries real weight in determining which proposals survive to the next round, which makes this closing window worth paying attention to if you care about how drug policy topics get represented on one of the country's biggest cultural stages.

How Many Cannabis and Psychedelics Panels Made the Cut This Year

Photo via Pexels.

Run the numbers year over year and the trend looks less like a straight line and more like a rollercoaster. For 2027, there are seven proposed sessions that reference cannabis in their descriptions and 20 that reference psychedelics. Compare that to the 2026 festival, which drew 16 cannabis-related proposals and more than 40 mentioning psychedelics -- already roughly double this year's count on both fronts.

Go back further and the numbers get bigger still. SXSW 2025 pulled in over a dozen cannabis-focused panels and more than 60 psychedelics proposals, making it one of the more robust years for drug policy programming at the festival. But 2023 complicates any simple narrative of psychedelics steadily eclipsing cannabis or vice versa: that year saw 61 cannabis-tagged proposals against just 32 for psychedelics, essentially the inverse of what's showing up in recent cycles.

That inconsistency matters. It's tempting to read this year's smaller numbers as proof that SXSW audiences and organizers are losing interest in drug policy as a programming category. But the jagged year-to-year swings suggest something messier is going on -- possibly shifts in how proposals get categorized, how submitters describe their own panels, or how SXSW structures its submission categories in the first place. A submitter pitching a hemp beverage panel might not think to use the word cannabis in their description at all, even if the topic is squarely about THC products.

No More Dedicated Tracks: A Structural Shift for 2027

Photo via Pexels.

One structural change probably explains a meaningful chunk of the drop-off: SXSW has done away with the dedicated cannabis and psychedelics tracks it ran in previous years. In past cycles, the festival organized submissions into named categories that let attendees and voters browse marijuana-focused or psychedelics-focused sessions as a cluster, which also made it easier for anyone tracking the space to get a full count of what was being proposed.

For 2027, that dedicated bucket is gone. Panels touching on cannabis or psychedelics now get folded into broader categories -- things like health, science, business, or culture -- rather than living under a standalone label. That's a meaningful shift in how the festival treats these topics: instead of being siloed as a niche subject area, drug policy content is being distributed across the general programming slate.

The practical effect is twofold. First, it likely deflates the raw count of proposals that explicitly reference cannabis or psychedelics in their text, since submitters aren't filling out a category field that used to nudge them toward using those terms. Second, it means anyone hoping to find these sessions in the SXSW program will need to dig a little more than in years past, scanning descriptions across unrelated categories rather than clicking into one convenient track. Whether that's a sign SXSW sees these topics as mainstream enough to not need special sorting, or simply a programming reshuffle unrelated to demand, isn't clear from the change alone.

Standout Proposals: THC Drinks, Air Quality, and Psilocybin Matching

Photo by YesMore Content via Unsplash.

A handful of this year's proposals show how far cannabis and psychedelics conversations have drifted from novelty territory into mainstream business and science framing. One panel pairs Willie Nelson's Juneshine Hemp Beverages with the cannabis-focused law firm Vicente LLP to talk through sustainable growth strategies in the hemp beverage category -- a corner of the market that barely existed a few years ago and now has entrenched national brands.

The proposal's framing is telling: it positions THC drinks as a disruptive wedge between two very differently sized industries, the roughly $120 billion alcohol market and the roughly $17 billion legal cannabis market. That's not a stoner-culture pitch; it's a beverage-industry disruption pitch, aimed at the same audience that shows up for SXSW's marketing and consumer trends programming.

Another standout proposal pulls in officials from the National Science Foundation to discuss air quality issues spanning an unusually wide range -- from emissions at cannabis cultivation facilities to deodorant aerosols to the air conditions affecting Olympic-level athletic performance. Cannabis, in that context, is one data point in a broader atmospheric science conversation rather than the headline.

On the psychedelics side, one proposal digs into matching specific psilocybin mushroom strains to individual patients based on cultivation methods and chemical profiles -- a level of clinical specificity that echoes precision-medicine conversations happening in pharmaceutical circles, not underground drug culture. Taken together, these sessions suggest cannabis and psychedelics are increasingly showing up as one thread within business, science, and health stories rather than as freestanding curiosities.

How the Voting Process Actually Works

Photo by Eren Li via Pexels.

The mechanics of getting a session on stage at SXSW start and end at panelpicker.sxsw.com, where anyone can submit a proposal or weigh in on ones already submitted. For the 2027 event -- covering both SXSW EDU and the main SXSW festival -- the submission window ran from June 23 through July 26, 2026. Once submissions closed, the process moved into its public voting phase.

That community voting period runs from August 5 through August 23, 2026, which means the window closes this coming Sunday. If you've got an opinion about whether a hemp beverage panel or a psilocybin-matching session deserves a slot on next March's schedule, this is the moment to act, not after the fact.

SXSW has been fairly transparent about how much weight public voting carries: the organization states that the majority of its conference sessions are sourced through PanelPicker community votes, combined with input from SXSW staff and a group called the PanelPicker Evaluator Committee, made up of industry professionals who review proposals for quality and relevance. Public votes don't guarantee a spot, but they factor meaningfully into which proposals make it past the initial screening.

Based on how previous years have played out, final lineup announcements typically come later in the year, after SXSW staff and its advisory board finish their own review process layered on top of the public vote. Anyone can create a free account and cast votes on however many proposals interest them -- no badge purchase or industry credential required. It's one of the more accessible points of public input into a festival that otherwise runs on invitation and paid access, and marijuana and psychedelics policy in particular varies enough state to state that panels like these often end up being genuinely useful primers for attendees navigating a patchwork legal landscape.

Take the raw numbers at face value and you might conclude that SXSW crowds are cooling on drug policy programming. Look closer at what changed -- the disappearance of dedicated cannabis and psychedelics tracks, the folding of these topics into business, science, and health categories -- and a different story emerges. This isn't a festival losing interest in marijuana and psychedelics; it's a festival that no longer treats those subjects as needing their own separate corner of the program.

That shift tracks with where the broader conversation has gone anyway. A panel about hemp beverages disrupting the alcohol industry, or scientists talking about cannabis farm emissions alongside deodorant and Olympic air quality, isn't drug culture content dressed up for a mainstream audience -- it's mainstream business and science content that happens to include cannabis as one variable among several. As always, the legal status of both cannabis and psychedelics differs significantly from state to state and country to country, so anyone attending sessions like these should treat them as informational rather than as guidance on what's permitted where they live.

If any of this is the kind of programming you want to see make the final cut, don't wait. The public voting window on panelpicker.sxsw.com closes this Sunday, and after that the decision moves out of the crowd's hands and into SXSW's internal review process.